Home/Filings/4/0001610717-24-000345
4//SEC Filing

Grais Linda 4

Accession 0001610717-24-000345

CIK 0001626971other

Filed

Jun 16, 8:00 PM ET

Accepted

Jun 17, 6:46 PM ET

Size

5.3 KB

Accession

0001610717-24-000345

Insider Transaction Report

Form 4
Period: 2024-06-13
Transactions
  • Award

    Stock Option (Right to Buy)

    2024-06-13+15,00015,000 total
    Exercise: $2.12Exp: 2034-06-13Common Stock (15,000 underlying)
Footnotes (1)
  • [F1]The underlying shares subject to the option vest and become exercisable as to 100% of the total number of shares subject to the option on the earlier of (i) the first anniversary of the grant date or (ii) the date of the 2025 Annual Meeting of the Issuer's stockholders, assuming continuous service as a director until such vesting date.

Documents

1 file

Issuer

Corvus Pharmaceuticals, Inc.

CIK 0001626971

Entity typeother

Related Parties

1
  • filerCIK 0001413306

Filing Metadata

Form type
4
Filed
Jun 16, 8:00 PM ET
Accepted
Jun 17, 6:46 PM ET
Size
5.3 KB